首页 | 本学科首页   官方微博 | 高级检索  
文章检索
  按 检索   检索词:      
出版年份:   被引次数:   他引次数: 提示:输入*表示无穷大
  收费全文   24033篇
  免费   1434篇
  国内免费   60篇
电工技术   311篇
综合类   25篇
化学工业   6140篇
金属工艺   537篇
机械仪表   555篇
建筑科学   840篇
矿业工程   47篇
能源动力   901篇
轻工业   3300篇
水利工程   177篇
石油天然气   134篇
无线电   1651篇
一般工业技术   4065篇
冶金工业   3169篇
原子能技术   167篇
自动化技术   3508篇
  2024年   44篇
  2023年   201篇
  2022年   627篇
  2021年   797篇
  2020年   528篇
  2019年   646篇
  2018年   996篇
  2017年   880篇
  2016年   928篇
  2015年   715篇
  2014年   955篇
  2013年   1648篇
  2012年   1396篇
  2011年   1635篇
  2010年   1201篇
  2009年   1181篇
  2008年   1138篇
  2007年   917篇
  2006年   845篇
  2005年   676篇
  2004年   564篇
  2003年   579篇
  2002年   490篇
  2001年   349篇
  2000年   360篇
  1999年   333篇
  1998年   1161篇
  1997年   699篇
  1996年   504篇
  1995年   306篇
  1994年   256篇
  1993年   249篇
  1992年   102篇
  1991年   124篇
  1990年   95篇
  1989年   104篇
  1988年   93篇
  1987年   102篇
  1986年   81篇
  1985年   91篇
  1984年   76篇
  1983年   74篇
  1982年   73篇
  1981年   84篇
  1980年   78篇
  1978年   52篇
  1977年   92篇
  1976年   121篇
  1975年   44篇
  1973年   44篇
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
1.
2.
3.
Context: The administration of pharmabiotics is a promising alternative to antimicrobial drugs for the treatment and/or prevention of female urogenital infections.

Objective: To design pharmabiotic formulations including bioactive ingredients of microbial origin combined with non-microbial substances and then to evaluate the stability of the combinations during freeze-drying and storage.

Materials and methods: Different formulations including Lactobacillus gasseri CRL 1263, Lactobacillus salivarius CRL 1328, salivaricin CRL 1328 (a bacteriocin) and non-microbial compounds (lactose, inulin and ascorbic acid) were assayed, and the ingredients were freeze-dried together or separately. The formulations were stored in gelatin capsules at 4?°C for 360?d.

Results: The viability of lactobacilli was affected to different extents depending on the strains and on the formulations assayed. L. salivarius and ascorbic acid were successfully combined only after the freeze-drying process. Salivaricin activity was not detected in formulations containing L. gasseri. However, when combined with ascorbic acid, lactose, inulin or L. salivarius, the bacteriocin maintained its activity for 360?d. The selected microorganisms proved to be compatible for their inclusion in multi-strain formulations together with lactose, inulin and ascorbic acid. Salivaricin could be included only in a L. salivarius CRL 1328 single-strain formulation together with non-microbial substances.

Conclusions: This study provides new insights into the design of urogenital pharmabiotics combining beneficial lactobacilli, salivaricin CRL 1328 and compounds with different functionalities.  相似文献   
4.
5.
This work investigates the effect of the addition of small amounts of Ru (0.5‐1 wt%) to carbon supported Co (10 wt%) catalysts towards both NaBH4 and NH3BH3 hydrolysis for H2 production. In the sodium borohydride hydrolysis, the activity of Ru‐Co/carbon catalysts was sensibly higher than the sum of the activities of corresponding monometallic samples, whereas for the ammonia borane hydrolysis, the positive effect of Ru‐Co systems with regard to catalytic activity was less evident. The performances of Ru‐Co bimetallic catalysts correlated with the occurrence of an interaction between Ru and Co species resulting in the formation of smaller ruthenium and cobalt oxide particles with a more homogeneous dispersion on the carbon support. It was proposed that Ru°, formed during the reduction step of the Ru‐Co catalysts, favors the H2 activation, thus enhancing the reduction degree of the cobalt precursor and the number of Co nucleation centers. A subsequent reduction of cobalt and ruthenium species also occurs in the hydride reaction medium, and therefore the state of the catalyst before the catalytic experiment determines the state of the active phase formed in situ. The different relative reactivity of the Ru and Co active species towards the two investigated reactions accounted for the different behavior towards NaBH4 and NH3BH3 hydrolysis.  相似文献   
6.
Phosphorodiamidate morpholino oligomers (PMOs) are oligonucleotide analogs that can be used for therapeutic modulation of pre‐mRNA splicing. Similar to other classes of nucleic acid‐based therapeutics, PMOs require delivery systems for efficient transport to the intracellular target sites. Here, artificial peptides based on the oligo(ethylenamino) acid succinyl‐tetraethylenpentamine (Stp), hydrophobic modifications, and an azide group are presented, which are used for strain‐promoted azide‐alkyne cycloaddition conjugation with splice‐switching PMOs. By systematically varying the lead structure and formulation, it is determined that the type of contained fatty acid and supramolecular assembly have a critical impact on the delivery efficacy. A compound containing linolenic acid with three cis double bonds exhibits the highest splice‐switching activity and significantly increases functional protein expression in pLuc/705 reporter cells in vitro and after local administration in vivo. Structural and mechanistic studies reveal that the lipopeptide PMO conjugates form nanoparticles, which accelerate cellular uptake and that the content of unsaturated fatty acids enhances endosomal escape. In an in vitro Duchenne muscular dystrophy exon skipping model using H2K‐mdx52 dystrophic skeletal myotubes, the highly potent PMO conjugates mediate significant splice‐switching at very low nanomolar concentrations. The presented aminoethylene‐lipopeptides are thus a promising platform for the generation of PMO‐therapeutics with a favorable activity/toxicity profile.  相似文献   
7.
8.
9.
10.
Using Java-based tools in multimedia collaborative environments accessed over the Internet can increase an application's client base. Most operating systems support Java, and its "compile once-run everywhere" architecture is easy to maintain and update. The Java-based tools presented here let users share Internet resources, including resources originally designed for single use.  相似文献   
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号